RPB0323

Pathogen Description

Target Pathogen Pathogen Name NCBI Taxonomy ID Order Family Genus Species Pathogen type
SARS-CoV-2 SARS-CoV-2, 2019-nCoV, COVID-19, COVID-19 virus, SARS2, Wuhan coronavirus, Human coronavirus 2019, COVID19, HCoV-19, SARS-2, SARS-CoV4 2697049 Nidovirales Coronaviridae Betacoronavirus Severe acute respiratory syndrome-related coronavirus virus

Primer Description

Primer Name Sequence(5'-3') Length(bp) Primer Final Concentration(μM) GC Content(%) Predicted Melting Temperature(℃) Molecular Weight(g/moles) Positions in GenBank accession number
N-primer F GCTTCTGACACAACTGTGTTCAC 23 400 nM 47.83 56.52 6974.6 \
N-primer R CGGCAGACTTCTCCACAGGAGT 22 400 nM 59.09 61.78 6720.43 \
N-probe Cy5-ACCTCAAACAGACACCATGG-BHQ1 20 120 nM 50 54.94 6064.04 \

Gene Description

Target Gene GenBank ID
N gene NC_045512.2

Assay Description

Application Assay Primer Designing Software Reaction Time(min) Assay Temperature(℃) Readout System(s) Limit of Detection(LoD) Sensitivity(%) Specificity(%)
a highly efficient and rapid microfluidiccartridge microsystem protocol for on-site NAAT of SARS-CoV-2 from oropharyngeal swabs. The ent tp-RPA Primer-BLAST 25 min 42 °C \ 20 copies per mL 0.02 copies per μL \

Publication Description

Year of Publication Title Author(s) Journal PMID DOI
2025 A fully integrated microfluidic cartridge for rapid and ultrasensitive nucleic acid detection from oropharyngeal swabs Bao Li,Baobao Lin,Wu Zeng,Yin Gu,Yulan Zhao,Peng Liu Lab on a Chip 39749581 10.1039/d4lc00770k

A fully integrated microfluidic cartridge for rapid and ultrasensitive nucleic acid detection from oropharyngeal swabs

Author(s):

Bao Li,Baobao Lin,Wu Zeng,Yin Gu,Yulan Zhao,Peng Liu

Journal:

Lab on a Chip

Year:

2025

Abstract:

Rapid and accurate molecular diagnostics are crucial for preventing the global spread of emerging infectious diseases. However, the current gold standard for nucleic acid detection, reverse transcription polymerase chain reaction (RT-PCR), relies heavily on traditional magnetic beads or silica membranes for nucleic acid extraction, resulting in several limitations, including time-consuming processes, the need for trained personnel, and complex equipment. Therefore, there is an urgent need for fully integrated nucleic acid detection technologies that are simple to operate, rapid, and highly sensitive to meet unmet clinical needs. In this study, we developed a novel, integrated microfluidic cartridge featuring a unique needle-plug/piston microvalve, which enables stable long-term reagent storage and flexible liquid handling for on-site nucleic acid analysis. Coupled with in situ tetra-primer recombinase polymerase amplification (tp-RPA), we achieved highly sensitive nucleic acid detection with a remarkable limit of detection of 20 copies per mL (0.02 copies per μL) and a short turnaround time of less than 30 minutes. To validate this assay, we tested 48 oropharyngeal swab samples. The positive detection rate reached 64.58% (31/48), significantly exceeding the approximately 50% positive detection rate of the traditional RT-PCR method. Furthermore, our assay demonstrated a 100% concordance rate with RT-PCR in detecting positive samples. Thus, we believe our microfluidic nucleic acid analysis system represents a promising approach for enabling rapid and ultrasensitive nucleic acid detection of pathogenic microorganisms in resource-limited settings and low-income areas.